Loading clinical trials...
Loading clinical trials...
This is a single-centre, open-label, mass balance and biotransformation study in healthy male subjects utilising a single oral dose of \[14C\] Yiqibuvir.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sunshine Lake Pharma Co., Ltd.
NCT07367958 · Healthy Male Subjects
NCT05245669 · Healthy Male Subjects
NCT03931590 · Healthy Male Subjects
NCT04814771 · Healthy Male Subjects
NCT06472531 · Healthy Male Subjects, Suspected Prostate Cancer
Shanghai xuhui central hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions